Anzeige
Mehr »
Login
Samstag, 22.03.2025 Börsentäglich über 12.000 News von 693 internationalen Medien
Breaking News: Syntheia meldet extremes User Wachstum: 10.000!!!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2QEQY | ISIN: SE0014829255 | Ticker-Symbol:
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
NEOLA MEDICAL AB Chart 1 Jahr
5-Tage-Chart
NEOLA MEDICAL AB 5-Tage-Chart

Aktuelle News zur NEOLA MEDICAL Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
05.03.Neola Medical AB: Neola Medical Granted New Patent Family in China, Protection for Lung Monitoring61Neola Medical AB has been granted a patent in China that strengthens the protection of the company's fundamental concept of measuring gases in body cavities using gas absorption spectroscopy for continuous...
► Artikel lesen
NEOLA MEDICAL Aktie jetzt für 0€ handeln
12.02.Neola Medical AB: Neola Medical Q4 Report 2024 - Received approval for initiation of first clinical pilot study on preterm born babies55Neola Medical achieved key milestones in 2024, instrumental to its planned FDA application: securing the CB certificate and successfully completing the Human Factors Validation study. These accomplishments...
► Artikel lesen
06.11.24Neola Medical AB: Neola Medical Q3 Report 2024 - Intensifying preparations for the first pivotal clinical study on preterm born babies in the U.S. to secure market approval by the FDA85Neola Medical is entering the clinical validation phase and is making significant strides toward securing market approval in the U.S., for continuous lung monitoring device, Neola®. The company's competitive...
► Artikel lesen
15.08.24Neola Medical AB: Neola Medical Q2 Report 2024 - Key milestones meet partial regulatory requirements for FDA approval62Neola Medical reached several critical milestones aligned with its business strategy, aimed at market approval by the FDA. The Human Factors Validation Study with Neola®, was successfully concluded...
► Artikel lesen
4 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1